GEA Pharma & Healthcare Insight stories
Insight stories
.jpg?h=1350&iar=0&w=2400&rev=1b429cc0c71d46d499711e0731d4a0cd&hash=BB51B496350FA3FA7A4E892151983C5E&mw=3840 "biopharma industry")
灌注分离机加速生物制药工艺
小型生物制药生产装备往往是激增创新医学治疗的推动力。GEA 正在利用灌注分离机彻底改变这些制造商的细胞收获能力，以实现效率优化的连续加工。适用的碟片式分离机首次被改造成紧凑的一次性机器，节省了空间、劳动力和精力，同时为提高生产产量和速度奠定了基础。
Continuous Innovation: How GEA is Leading the Future of Pharmaceutical Manufacturing
From the first ConsiGma® line in 2004 to the launch of CDC Flex today, GEA has been at the forefront of pharmaceutical innovation.
Continuous innovation is our commitment — to our customers, to the industry, and to a better world.
The new F-Gas Regulation and its impact on pharmaceutical freeze-drying
Discover how the new F-Gas Regulation (EU) 2024/573 affects pharmaceutical freeze-drying. Learn about stricter quotas, HFC phase-out, and innovative solutions for reducing environmental impact and energy consumption.
Innovating patient care with aseptic spray drying
At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology that promises to revolutionize pharmaceutical manufacturing.
Advancing pharmaceutical processing, transforming the future, saving lives
GEA and its partners are leading the way toward smaller, more flexible, continuous processing technologies that are transforming the future of pharmaceutical development and manufacturing.
疫苗生产技术在控制动物疾病方面起着至关重要的作用
家畜疾病通常对当地和全球经济产生巨大影响，并对公共卫生构成潜在威胁。疫苗可以作为抵抗传播且质量至关重要的有力工具。为了帮助我们迈向更接近无病世界的努力，GEA 提供了有助于这些高质量疫苗整个生产工艺的设备。
How continuous manufacturing is redefining the pharmaceutical supply chain
Continuous pharmaceutical manufacturing is no longer a niche trend. It’s already happening. Although implementation and knowledge transfer can be time consuming, early adopters are embarking on a new trajectory of business excellence, benefiting from numerous competitive advantages and staying ahead of the market.
当前与未来的制药情况
随着科学家不断解读癌症等疾病的基因组基础，越来越有可能针对相同的情况开发不同的药品并通过特定的基因档案锁定患者。 这样，不仅可以更小批量地生产所需的个性化药品，也要求制造技术更灵活，能够在生产不同的配方和专用产品之间切换。 最终目标是更高效地向市场供应更便宜、更安全的药品，让全球各地的人们都能获得更有效的药物。
Development of new vaccines
GEA, the globally active mechanical and plant engineering company, takes its role in the fight against the coronavirus — and any other — epidemic, extremely seriously. But how do we prove that a vaccine against the virus works: is it safe for children, the elderly and/or pregnant women? It will no doubt take some time to produce 7 billion doses, which is something that cannot be done overnight; but, first, we need to be sure that it works safely … for everyone!
糖尿病战争中的胰岛素
国际糖尿病联盟 (IDF) 估计，截至 2030，将有超过 5.5 亿糖尿病患者，占地球上所有成年人数的 10%。从世界卫生组织的数字中可看出，糖尿病致死人数届时将增加三分之二。
The unsung heroes of global health and well-being
When we consider the concept of health, we generally think about being free from injury or illness. We might look at a person’s mental or physical condition, or delve more deeply into nutrition, exercise, sleep and the environment we live in. In recent times, vaccines and medicines have taken center stage as the world battles the ongoing pandemic. Yet, often behind the scenes and anonymous, a vast array of technologies and innovations are working hard, every day, to ensure that the food, drugs, water and energy that we use to stay well are safe, reliable and sustainable. At the heart of many of those processes – and supporting healthy living – is GEA equipment.
